Please Wait
Applying Filters...
menu
    • menu
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Laboratorium Ofichem, offering a flexible, high-tech environment to produce broad range of APIs for Human & Vet pharmaceutical markets.

    Virtual Booth

    Contact Supplier

    Menu

    Onabotulinumtoxina

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Botox Cosmetic Picks Entrepreneurs for Confidence Project
    Botox Cosmetic Picks Entrepreneurs for Confidence Project

    22 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/botox-cosmetic-onabotulinumtoxina-selects-this-years-entrepreneurs-for-the-confidence-project-302510168.html

    PR NEWSWIRE
    22 Jul 2025
    Share Share
    Liquid Botulinum Toxin Type A Gets FDA IND Approval
    Liquid Botulinum Toxin Type A Gets FDA IND Approval

    25 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/the-world-first-liquid-formulation-of-recombinant-botulinum-toxin-type-a-has-obtained-ind-approval-by-the-fda-302258483.html

    PR NEWSWIRE
    25 Sep 2024
    Share Share
    Evolus Introduces Nuceiva® In Australia
    Evolus Introduces Nuceiva® In Australia

    30 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240730657453/en

    BUSINESSWIRE
    30 Jul 2024
    Share Share
    Evexta Bio Appoints Shawn M. Leland As Chairman
    Evexta Bio Appoints Shawn M. Leland As Chairman

    19 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240619024966/en

    BUSINESSWIRE
    19 Jun 2024
    Share Share
    Evolus Launches Nuceiva In Spain Broadening International Presence
    Evolus Launches Nuceiva In Spain Broadening International Presence

    12 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240612853482/en

    BUSINESSWIRE
    12 Jun 2024
    Share Share
    Ipsen's Biologic Dysport (AbobotulinumtoxinA) Receives Approval in the U.S.
    Ipsen's Biologic Dysport (AbobotulinumtoxinA) Receives Approval in the U.S.

    21 Sep 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125274

    FDA
    21 Sep 2023
    Share Share